Ebola Virus Disease - 26 Studies Found
| Completed |
: Efficacy of Favipiravir Against Severe Ebola Virus Disease : Ebola Virus Disease : 2016-01-19 :
|
| Recruiting |
: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response : Ebola Virus Disease : 2017-03-30 |
| Recruiting |
: Multiple Treatments for Ebola Virus Disease (EVD) : Ebola Virus Disease : 2015-03-01 :
|
| Recruiting |
: Partnership for Research on Ebola VACcinations : Ebola Virus Disease : 2016-08-16 :
|
| Enrolling by invitation |
: A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease : Acute Ebola Virus Disease : 2014-11-04 : Biological: INTERCEPT Plasma Plasma will be collected from eligible volunteer donors who have recovered |
| Completed |
: Efficacy of Favipiravir Against Ebola (JIKI) : Ebola Virus Disease : 2014-12-16 : Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg |
| Recruiting |
: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up : Ebola Virus Disease : 2015-04-30 |
| Completed |
: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. : Ebola Virus Disease : 2014-12-22 :
|
| Enrolling by invitation |
: Persistence of the Immune Response After Ebola Vaccine Immunisation : Ebola Virus Disease : 2017-05-02 |
| Enrolling by invitation |
: Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment : Ebola Virus Disease : 2015-01-05 : Procedure: Convalescent Plasma Treatment This pilot trial will treat subjects in the ECP Group with ECP |